Can you get Mounjaro on the NHS in Scotland?

Step 1: Understand why Scotland's route is different

A widely held misconception is that a NICE recommendation automatically opens up NHS prescribing across the whole of the UK. It does not. Health policy is devolved: NHS England operates under NICE technology appraisals, including TA1026 which recommended tirzepatide in December 2024. NHS Scotland is not bound by NICE TAs in the same way. Instead, the Scottish Medicines Consortium (SMC) and local health board policies govern which medicines are routinely commissioned. As of summer 2026, tirzepatide for weight management does not sit on the standard SMC formulary in the same position it occupies south of the border.

This matters practically. Even if your BMI and health history would qualify you under NICE's criteria, your GP in Aberdeen or Dundee is working within a different framework to a GP in Manchester. That is not a failing, it reflects how the four nations fund and prioritise medicines independently. For a broader picture of how Mounjaro sits across the NHS as a whole, that page covers the England rollout and the wider policy landscape.

What NHS Scotland does offer is access to specialist weight management services, where clinicians can consider unlicensed or off-formulary prescribing in complex cases. Referral thresholds and waiting times vary considerably by health board. The eligibility criteria for Mounjaro in NHS Scotland are explained in detail separately, including how health board variation affects your individual position.

Step 2: Check whether your health board has a local pathway

Scotland's 14 regional health boards have latitude to commission medicines beyond the national SMC framework when clinical evidence justifies it. A small number of boards have developed interim or pilot pathways for tirzepatide, typically through tier 3 or tier 4 obesity services. These are not uniform, and knowing whether your board has one requires either a GP conversation or a direct enquiry to the relevant specialist service.

If you are already under a specialist weight management team in Scotland, ask directly whether tirzepatide is available within your pathway. Specialist prescribers working in obesity medicine have more flexibility than a GP prescribing from a standard formulary. How a Mounjaro NHS Scotland prescription works in practice covers the referral and specialist-prescribing route in more detail.

It is also worth knowing that NHS inform Scotland provides regularly updated guidance on diabetes and weight-loss medicines, including semaglutide and tirzepatide, and is the most reliable patient-facing source for Scotland-specific information. NHS inform Scotland's weight-loss medicine guidance explains the current position clearly and is updated when pathways change.

Step 3: Weigh up the private prescription route

For people in Scotland who meet the clinical criteria but face long waiting lists or a health board without a Mounjaro pathway, a private prescription from a GPhC-registered online pharmacy is a legal and regulated option. The medicine is the same licensed UK product regardless of whether the prescription originates from the NHS or a private prescriber, what changes is who pays and how quickly you can start.

Private pricing for Mounjaro varies by dose and provider. Since Eli Lilly raised UK list prices in September 2025, reported market prices have ranged roughly from £149 to £375 per month depending on the dose. For context on what those figures include and exclude, a straightforward UK cost comparison sets out what you should expect a legitimate price to cover. Worth checking before you commit anywhere.

At nume, every order starts with a free consultation reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not a set of automated rules. If clinically suitable, treatment is dispatched the same day you order (before 12pm, Monday to Friday) and arrives free the next working day via DPD in plain packaging. There is no subscription and no auto-renewal; every repeat is clinically re-checked. Whether Mounjaro is available on the NHS in Scotland right now is a separate question from whether you can access it privately, and both questions have honest answers.

Step 4: Explore your treatment options with a prescriber

If you are considering starting Mounjaro (whether through whatever NHS Scotland pathway your board offers or through a private prescription) a prescriber will assess your BMI, your medical history, any current medicines, and the presence of weight-related conditions. That assessment is not a box-ticking exercise. It determines the starting dose, how titration should progress, and whether any interactions need managing.

NICE's own appraisal of tirzepatide (TA1026) drew on SURMOUNT-1 trial data showing average body-weight reductions of around 20 to 21 per cent at the highest dose over 72 weeks. Those results come from a medically supervised setting with lifestyle support alongside treatment. Mounjaro's full clinical profile covers the evidence, the side-effect picture, and how treatment typically progresses. For people in Scotland specifically, how the NHS England rollout compares to Scotland's current position is useful background when you are working out your next move.

If you are ready to explore whether private treatment is right for you, our straightforward ordering process is explained in full before you commit, and starting your free consultation means our prescribers will give you a clear, honest assessment of your options.